Cancer cost profiles: The Epicost estimation approach
Sustainability of cancer burden is becoming increasingly central in the policy makers' debate, and poses a challenge for the welfare systems, due to trends towards greater intensity of healthcare service use, which imply increasing costs of cancer care. Measuring and projecting the economic bur...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2022.974505/full |
_version_ | 1811271836982312960 |
---|---|
author | Silvia Francisci Guilia Capodaglio Anna Gigli Cristina Mollica Stefano Guzzinati |
author_facet | Silvia Francisci Guilia Capodaglio Anna Gigli Cristina Mollica Stefano Guzzinati |
author_sort | Silvia Francisci |
collection | DOAJ |
description | Sustainability of cancer burden is becoming increasingly central in the policy makers' debate, and poses a challenge for the welfare systems, due to trends towards greater intensity of healthcare service use, which imply increasing costs of cancer care. Measuring and projecting the economic burden associated with cancer and identifying effective policies for minimising its impact are important issues for healthcare systems. Scope of this paper is to illustrate a novel comprehensive approach (called Epicost) to the estimation of the economic burden of cancer, based on micro-data collected from multiple data sources. It consists of a model of cost analysis to estimate the amount of reimbursement payed by the National Health Service to health service providers (hospitals, ambulatories, pharmacies) for the expenses incurred in the diagnoses and treatments of a cohort of cancer patients; these cancer costs are estimated in various phases of the disease reflecting patients' patterns of care: initial, monitoring and final phase. The main methodological features are illustrated using a cohort of colon cancer cases from a Cancer Registry in Italy. This approach has been successfully implemented in Italy and it has been adapted to other European countries, such as Belgium, Norway and Poland in the framework of the Innovative Partnership for Action Against Cancer (iPAAC) Joint Action, sponsored by the European Commission. It is replicable in countries/regions where population-based cancer registry data is available and linkable at individual level with administrative data on costs of care. |
first_indexed | 2024-04-12T22:28:15Z |
format | Article |
id | doaj.art-5a6de2f408674addb80f2e3501d70617 |
institution | Directory Open Access Journal |
issn | 2296-2565 |
language | English |
last_indexed | 2024-04-12T22:28:15Z |
publishDate | 2022-09-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Public Health |
spelling | doaj.art-5a6de2f408674addb80f2e3501d706172022-12-22T03:14:03ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-09-011010.3389/fpubh.2022.974505974505Cancer cost profiles: The Epicost estimation approachSilvia Francisci0Guilia Capodaglio1Anna Gigli2Cristina Mollica3Stefano Guzzinati4National Centre for Disease Prevention and Health Promotion, National Health Institute, Rome, ItalyScreening and Health Impact Assessment Unit, Azienda Zero, Padova, ItalyInstitute for Research on Population and Social Policies, National Research Council, Rome, ItalyDepartment of Statistical Sciences, Sapienza University of Rome, Rome, ItalyRegional Epidemiological Service, Veneto Cancer Registry (RTV), Azienda Zero, Padova, ItalySustainability of cancer burden is becoming increasingly central in the policy makers' debate, and poses a challenge for the welfare systems, due to trends towards greater intensity of healthcare service use, which imply increasing costs of cancer care. Measuring and projecting the economic burden associated with cancer and identifying effective policies for minimising its impact are important issues for healthcare systems. Scope of this paper is to illustrate a novel comprehensive approach (called Epicost) to the estimation of the economic burden of cancer, based on micro-data collected from multiple data sources. It consists of a model of cost analysis to estimate the amount of reimbursement payed by the National Health Service to health service providers (hospitals, ambulatories, pharmacies) for the expenses incurred in the diagnoses and treatments of a cohort of cancer patients; these cancer costs are estimated in various phases of the disease reflecting patients' patterns of care: initial, monitoring and final phase. The main methodological features are illustrated using a cohort of colon cancer cases from a Cancer Registry in Italy. This approach has been successfully implemented in Italy and it has been adapted to other European countries, such as Belgium, Norway and Poland in the framework of the Innovative Partnership for Action Against Cancer (iPAAC) Joint Action, sponsored by the European Commission. It is replicable in countries/regions where population-based cancer registry data is available and linkable at individual level with administrative data on costs of care.https://www.frontiersin.org/articles/10.3389/fpubh.2022.974505/fullcancer epidemiologycancer cost evaluationcancer prevalence by phase of carecancer registryadministrative data sources |
spellingShingle | Silvia Francisci Guilia Capodaglio Anna Gigli Cristina Mollica Stefano Guzzinati Cancer cost profiles: The Epicost estimation approach Frontiers in Public Health cancer epidemiology cancer cost evaluation cancer prevalence by phase of care cancer registry administrative data sources |
title | Cancer cost profiles: The Epicost estimation approach |
title_full | Cancer cost profiles: The Epicost estimation approach |
title_fullStr | Cancer cost profiles: The Epicost estimation approach |
title_full_unstemmed | Cancer cost profiles: The Epicost estimation approach |
title_short | Cancer cost profiles: The Epicost estimation approach |
title_sort | cancer cost profiles the epicost estimation approach |
topic | cancer epidemiology cancer cost evaluation cancer prevalence by phase of care cancer registry administrative data sources |
url | https://www.frontiersin.org/articles/10.3389/fpubh.2022.974505/full |
work_keys_str_mv | AT silviafrancisci cancercostprofilestheepicostestimationapproach AT guiliacapodaglio cancercostprofilestheepicostestimationapproach AT annagigli cancercostprofilestheepicostestimationapproach AT cristinamollica cancercostprofilestheepicostestimationapproach AT stefanoguzzinati cancercostprofilestheepicostestimationapproach |